e-Drug3D

758

LOTEPREDNOL ETABONATE


INN
LOTEPREDNOL ETABONATE

cas 82034-46-6
CLASS

SENSORY
ANTIINFLAMMATORY
ANTIALLERGIC
CORTICOSTEROIDS

ROUTE (list)

OPHTHALMIC

ATC code

S01BA14
S01CA12

PK parameters

Solubility

NOT SOLUBLE IN WATER (BUT HIGHLY LIPID SOLUBLE)


Target

TARGET GLUCOCORTICOID RECEPTOR

DrugCentral

Glucocorticoid receptor UNIPROT P04150 NR3C1

Download SDF file chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate

Formula:
C24H31ClO7

Calculated chemical properties:

MW 466.94
NB_atoms 32
XLogP 3.92
PSA 87.843
NB_HD 1
NB_HA 7
fsp3 0.71
Lipinski(0=no;1=yes) 1

FDA
NDA 020583 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEMAX (BAUSCH AND LOMB) APPROVAL= AP YEAR= 1998 NEWMOLECULARENTITY
NDA 020803 (pdf not found) INN (LOTEPREDNOL ETABONATE) ALREX (BAUSCH AND LOMB) APPROVAL= AP YEAR= 1998
NDA 020841 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEMAX (PHARMOS) APPROVAL= AP YEAR= 1998 NEWAPPLICATION DISCONTINUED
NDA 050804 (pdf not found) INN (LOTEPREDNOL ETABONATE ; TOBRAMYCIN) ZYLET (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2004
NDA 200738 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEMAX (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2011
NDA 202872 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEMAX (BAUSCH AND LOMB INC) APPROVAL= AP YEAR= 2012
NDA 210565 (pdf not found) INN (LOTEPREDNOL ETABONATE) INVELTYS (ALCON LABS INC) APPROVAL= AP YEAR= 2018
NDA 207609 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (SENTISS) APPROVAL= AP YEAR= 2019
NDA 208219 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEMAX SM (BAUSCH AND LOMB INC) APPROVAL= AP YEAR= 2019
NDA 210933 (pdf not found) INN (LOTEPREDNOL ETABONATE) EYSUVIS (ALCON LABS INC) APPROVAL= AP YEAR= 2020 NEWAPPLICATION
NDA 212080 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (SENTISS) APPROVAL= AP YEAR= 2021
NDA 212450 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (SUN PHARM) APPROVAL= AP YEAR= 2021
NDA 215933 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (SENTISS) APPROVAL= AP YEAR= 2023
NDA 213956 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (HIKMA) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 215384 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (SUN PHARM) APPROVAL= AP YEAR= 2023
NDA 215550 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (LUPIN LTD) APPROVAL= AP YEAR= 2023
NDA 215719 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (LUPIN LTD) APPROVAL= AP YEAR= 2024
NDA 215203 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (PADAGIS US) APPROVAL= AP YEAR= 2024
NDA 216345 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (AMNEAL) APPROVAL= AP YEAR= 2024
NDA 215204 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (PADAGIS US) APPROVAL= AP YEAR= 2025
NDA 217484 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (AMNEAL) APPROVAL= AP YEAR= 2025
NDA 218087 (pdf not found) INN (LOTEPREDNOL ETABONATE) LOTEPREDNOL ETABONATE (LUPIN LTD) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL